These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 11550985

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis.
    Ramanan AV, Schneider R.
    J Rheumatol; 2003 Feb; 30(2):401-3. PubMed ID: 12563702
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Macrophage activation syndrome associated with etanercept in a child with systemic onset juvenile idiopathic arthritis.
    Nádia EA, Carvalho JF, Bonfá E, Lotito AP, Silva CA.
    Isr Med Assoc J; 2009 Oct; 11(10):635-6. PubMed ID: 20077954
    [No Abstract] [Full Text] [Related]

  • 9. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations.
    Foell D, Wittkowski H, Hammerschmidt I, Wulffraat N, Schmeling H, Frosch M, Horneff G, Kuis W, Sorg C, Roth J.
    Arthritis Rheum; 2004 Apr; 50(4):1286-95. PubMed ID: 15077313
    [Abstract] [Full Text] [Related]

  • 10. A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis.
    Smith JA, Thompson DJ, Whitcup SM, Suhler E, Clarke G, Smith S, Robinson M, Kim J, Barron KS.
    Arthritis Rheum; 2005 Feb 15; 53(1):18-23. PubMed ID: 15696578
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The treatment of psoriasis and psoriatic arthritis with etanercept: practical considerations on monotherapy, combination therapy, and safety.
    Yamauchi PS, Gindi V, Lowe NJ.
    Dermatol Clin; 2004 Oct 15; 22(4):449-59, ix. PubMed ID: 15450340
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of etanercept on insulin secretion and insulin sensitivity in a randomized trial with psoriatic patients at risk for developing type 2 diabetes mellitus.
    Martínez-Abundis E, Reynoso-von Drateln C, Hernández-Salazar E, González-Ortiz M.
    Arch Dermatol Res; 2007 Nov 15; 299(9):461-5. PubMed ID: 17726611
    [Abstract] [Full Text] [Related]

  • 19. Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients.
    Gerloni V, Pontikaki I, Gattinara M, Fantini F.
    Ann Rheum Dis; 2008 Aug 15; 67(8):1145-52. PubMed ID: 17981916
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.